Interferon gamma inhibits transmissible gastroenteritis virus infection mediated by an IRF1 signaling pathway.
Animals
Cell Line
Chlorocebus aethiops
Gastroenteritis, Transmissible, of Swine
/ immunology
Interferon Regulatory Factor-1
/ genetics
Interferon-alpha
/ immunology
Interferon-gamma
/ immunology
RNA Interference
RNA, Small Interfering
/ genetics
Signal Transduction
/ immunology
Swine
Transmissible gastroenteritis virus
/ immunology
Vero Cells
Journal
Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
25
01
2019
accepted:
01
07
2019
pubmed:
7
8
2019
medline:
11
10
2019
entrez:
7
8
2019
Statut:
ppublish
Résumé
Interferon gamma (IFN-γ) is best known for its ability to regulate host immune responses; however, its direct antiviral activity is less well studied. Transmissible gastroenteritis virus (TGEV) is an economically important swine enteric coronavirus and causes acute diarrhea in piglets. At present, little is known about the function of IFN-γ in the control of TGEV infection. In this study, we demonstrated that IFN-γ inhibited TGEV infection directly in ST cells and intestine epithelial IPEC-J2 cells and that the anti-TGEV activity of IFN-γ was independent of IFN-α/β. Moreover, IFN-γ suppressed TGEV infection in ST cells more efficiently than did IFN-α, and the combination of IFN-γ and IFN-α displayed a synergistic effect against TGEV. Mechanistically, using overexpression and functional knockdown experiments, we demonstrated that porcine interferon regulatory factor 1 (poIRF1) elicited by IFN-γ primarily mediated IFN-γ signaling cascades and the inhibition of TGEV infection by IFN-γ. Importantly, we found that TGEV elevated the expression of poIRF1 and IFN-γ in infected small intestines and peripheral blood mononuclear cells. Thus, IFN-γ plays a crucial role in curtailing enteric coronavirus infection and may serve as an effective prophylactic and/or therapeutic agent against TGEV infection.
Identifiants
pubmed: 31385116
doi: 10.1007/s00705-019-04362-2
pii: 10.1007/s00705-019-04362-2
pmc: PMC7086799
doi:
Substances chimiques
Interferon Regulatory Factor-1
0
Interferon-alpha
0
RNA, Small Interfering
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2659-2669Subventions
Organisme : the National Key R & D Program of China
ID : 2017YFD0502200
Organisme : National Natural Science Foundation of China
ID : 31772718
Références
Viruses. 2015 Nov 17;7(11):5908-18
pubmed: 26593937
Comp Immunol Microbiol Infect Dis. 2012 Jul;35(4):289-301
pubmed: 22333156
J Virol. 2012 Dec;86(23):12655-64
pubmed: 22973039
Front Immunol. 2014 Feb 06;5:15
pubmed: 24567732
Science. 1994 Jun 24;264(5167):1921-4
pubmed: 8009222
J Virol. 2015 Jan;89(1):312-22
pubmed: 25320312
Cell Rep. 2017 Nov 7;21(6):1600-1612
pubmed: 29117564
Asian Pac J Allergy Immunol. 2016 Sep;34(3):236-241
pubmed: 27001652
J Immunol. 2011 Feb 1;186(3):1685-93
pubmed: 21178011
Oncoimmunology. 2012 Jul 1;1(4):533-534
pubmed: 22754776
Vet Microbiol. 1995 Jun;45(1):59-70
pubmed: 7653029
Immunology. 2006 May;118(1):78-87
pubmed: 16630025
J Virol. 2017 Jun 26;91(14):
pubmed: 28468880
PLoS Pathog. 2015 Nov 12;11(11):e1005263
pubmed: 26562011
Virology. 2004 Nov 10;329(1):11-7
pubmed: 15476870
Emerg Microbes Infect. 2017 Aug 23;6(8):e74
pubmed: 28831195
PLoS Pathog. 2011 Sep;7(9):e1002230
pubmed: 21909274
Antiviral Res. 2005 Jan;65(1):23-34
pubmed: 15652968
J Virol. 2015 Mar;89(6):3332-42
pubmed: 25589635
Curr Top Microbiol Immunol. 2007;316:119-54
pubmed: 17969446
Eur J Immunol. 1992 Sep;22(9):2403-12
pubmed: 1387613
Viral Immunol. 2007 Dec;20(4):571-84
pubmed: 18158731
Am J Vet Res. 1994 Apr;55(4):494-501
pubmed: 8017695
Am J Vet Res. 1980 Feb;41(2):219-23
pubmed: 6245603
J Leukoc Biol. 2004 Feb;75(2):163-89
pubmed: 14525967
Viral Immunol. 2010 Apr;23(2):135-49
pubmed: 20373994
Vet Res. 2001 Jan-Feb;32(1):71-9
pubmed: 11254179
Res Immunol. 1997 May;148(4):247-56
pubmed: 9300531
J Virol. 1988 Jan;62(1):8-11
pubmed: 2824858
J Exp Med. 2013 Sep 23;210(10):1929-36
pubmed: 23999497
Trends Immunol. 2002 Feb;23(2):96-101
pubmed: 11929133
J Virol. 1968 Oct;2(10):955-61
pubmed: 4302013
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4239-44
pubmed: 22371602
PLoS Pathog. 2014 Mar 27;10(3):e1003999
pubmed: 24675692
J Virol. 2018 Jul 17;92(15):
pubmed: 29769338
J Biol Chem. 2005 Apr 1;280(13):12896-901
pubmed: 15695523
Annu Rev Immunol. 1993;11:571-611
pubmed: 8476573
Virol J. 2018 Jun 19;15(1):102
pubmed: 29914507